---
figid: PMC7198187__gr1_lrg
figtitle: Immunomodulation in COVID-19
organisms:
- NA
pmcid: PMC7198187
filename: gr1_lrg.jpg
figlink: pmc/articles/PMC7198187/figure/fig1/
number: F1
caption: 'SARS-CoV-2 interaction with the inflammatory system and therapy targets
  within the systemTLR4, AT1R, IL-6, IL-1, IL-18, type 1 IFNs, and IFN-γ receptor
  binding activates specific signalling cascades and translocation of nuclear transcription
  factors into the nucleus (blue ellipse), where they interact with their respective
  chaperones (NF-KB) or their targeting sequences on DNA (ISRE, GAS) to activate the
  production of multiple proteins including additional cytokines, chemokines, cell
  surface molecules, and more. SARS-CoV-2 also directly interacts with ACE2 (via S
  protein) causing uninhibited Ang II activation of AT1R while also decreasing TLR4
  inhibition; in addition, SARS-CoV-2 inhibits TYK 2 (vis NSP1), further driving inflammation
  by causing downstream effects that overlap with the immunomodulatory pathway. Anticytokine,
  JAK inhibitors, and antihypertensives can limit hyperinflammation by interacting
  and inhibiting these signalling cascades. ACE=angiotensin converting enzyme. Ang=angiotensin.
  ATR1=type 1 angiotensin II receptor. AT2R=type 2 angiotensin II receptor. COX=cyclooxygenase.
  GAS=IFN-γ activation site. ICAM=intercellular adhesion molecule. IL=interleukin.
  IFN=interferon. IRF=IFN regulatory factor. ISG=IFN-stimulated gene. ISRE=IFN-stimulated
  response element. JAK=Janus kinase. MCP=monocyte chemoattractant protein. NSP=non-structural
  protein. PD-1=programmed cell death 1. R=receptor. SARS-CoV-2=severe acute respiratory
  syndrome coronavirus 2. TGF=transforming growth factor. TLR=toll-like receptor.
  TNF=tumour necrosis factor. TRIF=TIR-domain-containing adapter-inducing interferon-β.
  TXA=thromboxane. TYK=tyrosine kinase. VEGF=vascular endothelial growth factor. *JAK
  inhibitors: ruxolitinib, tofacitinib, baricitinib, peficitinib, fedratinib, and
  upadacitinib.'
papertitle: Immunomodulation in COVID-19.
reftext: Nicholas E Ingraham, et al. Lancet Respir Med. 2020 Jun;8(6):544-546.
year: '2020'
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.9372713
figid_alias: PMC7198187__F1
figtype: Figure
organisms_ner:
- Homo sapiens
redirect_from: /figures/PMC7198187__F1
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC7198187__gr1_lrg.html
  '@type': Dataset
  description: 'SARS-CoV-2 interaction with the inflammatory system and therapy targets
    within the systemTLR4, AT1R, IL-6, IL-1, IL-18, type 1 IFNs, and IFN-γ receptor
    binding activates specific signalling cascades and translocation of nuclear transcription
    factors into the nucleus (blue ellipse), where they interact with their respective
    chaperones (NF-KB) or their targeting sequences on DNA (ISRE, GAS) to activate
    the production of multiple proteins including additional cytokines, chemokines,
    cell surface molecules, and more. SARS-CoV-2 also directly interacts with ACE2
    (via S protein) causing uninhibited Ang II activation of AT1R while also decreasing
    TLR4 inhibition; in addition, SARS-CoV-2 inhibits TYK 2 (vis NSP1), further driving
    inflammation by causing downstream effects that overlap with the immunomodulatory
    pathway. Anticytokine, JAK inhibitors, and antihypertensives can limit hyperinflammation
    by interacting and inhibiting these signalling cascades. ACE=angiotensin converting
    enzyme. Ang=angiotensin. ATR1=type 1 angiotensin II receptor. AT2R=type 2 angiotensin
    II receptor. COX=cyclooxygenase. GAS=IFN-γ activation site. ICAM=intercellular
    adhesion molecule. IL=interleukin. IFN=interferon. IRF=IFN regulatory factor.
    ISG=IFN-stimulated gene. ISRE=IFN-stimulated response element. JAK=Janus kinase.
    MCP=monocyte chemoattractant protein. NSP=non-structural protein. PD-1=programmed
    cell death 1. R=receptor. SARS-CoV-2=severe acute respiratory syndrome coronavirus
    2. TGF=transforming growth factor. TLR=toll-like receptor. TNF=tumour necrosis
    factor. TRIF=TIR-domain-containing adapter-inducing interferon-β. TXA=thromboxane.
    TYK=tyrosine kinase. VEGF=vascular endothelial growth factor. *JAK inhibitors:
    ruxolitinib, tofacitinib, baricitinib, peficitinib, fedratinib, and upadacitinib.'
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - IL1B
  - IL6
  - JAK1
  - JAK2
  - JAK3
  - TYK2
  - ACE
  - ACE2
  - AGTR1
  - IRF4
  - PRDM1
  - TIGIT
  - COX2
  - PTGS2
  - MTCO2P12
  - TLR4
  - TRIM69
  - TICAM1
  - MYD88
  - VEGFA
  - VEGFB
  - VEGFC
  - VEGFD
  - PGF
  - ICAM1
  - CCL2
  - IL12A
  - IL12B
  - TNF
  - IL18
  - CXCL8
  - CRK
  - MAPK14
  - MAPK1
  - AIMP2
  - GRAP2
  - AHSA1
  - POLDIP2
  - MAPK11
  - MAPK12
  - MAPK13
  - IL1R1
  - NFKB1
  - RELA
  - RELB
  - REL
  - NFKB2
  - SH2D3A
  - IFNA1
  - AR
  - IRF9
  - STAT2
  - PDCD1
  - RPL17
  - RPL17-C18orf32
  - STAT1
  - STAT3
  - IL6R
  - TGFB1
  - TGFB2
  - TGFB3
  - GAST
  - GALNS
  - PAGR1
  - Losartan
  - Enalapril
  - captopril
  - TXA
  - SARS-COV-2
---
